Dishman Carbo Amcis Ltd

DCAL NSE Healthcare Pharmaceuticals
₹167.25
-0.14%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.46.
  • Comfortable interest cover: operating profit covers interest about 3.3 times.
  • Profit has compounded about 21% a year over five years.
  • Promoters hold a majority stake (59.32%).

!Watch-points

  • Return on equity is on the lower side at 1.6%.
  • Return on capital employed is on the lower side at 3.1%.
  • Net profit margin is slim at 3.3%.
  • Recent profit growth (-85%) is slower than the five-year pace (21%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.32

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
5 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 2,622 Cr
Current Price₹ 167.25
High / Low₹ 321.95 / 128.50
Stock P/E26.889069
Book Value₹ 426.00
Dividend Yield0%
ROCE3.14%
ROE1.58%
Face Value₹ 2.00
Debt to Equity0.46
PEG Ratio1.04
EV / EBITDA6.30
Industry PE35.70
P/B Ratio0.39177427
EPS₹ 6.22
Debt₹ 3,076 Cr
PAT Margin3.31%
Cash PAT₹ 436 Cr
ICR3.25
Promoter Holding59.32%
FII Holding6.86%
DII Holding2.06%
Public Holding31.76%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 9.00%
3 Years 7.00%
TTM 0.00%
Compounded Profit Growth
10 Years
5 Years 21.00%
3 Years 140.00%
TTM -85.00%
Stock Price CAGR
10 Years
5 Years -5.00%
3 Years 2.00%
1 Year -37.00%
Return on Equity
10 Years 1.00%
5 Years 0.00%
3 Years 0.00%
Last Year 2.00%
Educational data only. Not a recommendation to buy, sell or hold any security.